Recent Posts
- HealthInvest June 2026: A Look Inside Australia’s Healthcare Innovations
- HealthInvest Returns for 2026: Meet the Companies Shaping Australian Life Sciences
- Lifesaving Capital: How impact investing is shaping the future of biotech
- Investor Relations: the quiet advantage powering ASX microcaps
- HealthInvest Sydney: Life Sciences in the Investor Spotlight
Archives
Innovating sleep apnoea care

Sleep apnoea is a potentially serious condition but only one in five patients are in care.
Oventus (ASX:OVN) is innovating sleep apnoea care with its patented airway design that creates a 'second nose'. Using CAD software to create a 3D drawing of the patient’s mouth and bite, Oventus uses 3D printing technology to manufacture these custom-made medical-grade mouthguards from titanium.
April 2nd, 2018
by
IR Dept
Read More
- 1
